Triple

T2898669
Position Surface form Disambiguated ID Type / Status
Subject AstraZeneca global corporate headquarters E62602 entity
Predicate operator P179 FINISHED
Object AstraZeneca E118527 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: AstraZeneca | Statement: [AstraZeneca global corporate headquarters, operator, AstraZeneca]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: AstraZeneca
Context triple: [AstraZeneca global corporate headquarters, operator, AstraZeneca]
  • A. AstraZeneca chosen
    AstraZeneca is a global biopharmaceutical company known for researching, developing, and manufacturing prescription medicines across areas such as oncology, cardiovascular, respiratory, and immunology.
  • B. GlaxoSmithKline
    GlaxoSmithKline is a global biopharmaceutical company known for developing and manufacturing prescription medicines, vaccines, and consumer healthcare products.
  • C. Novartis
    Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
  • D. Pfizer
    Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
  • E. Eisai
    Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69ab4c3e070c8190b78d3d2c005876dd completed March 6, 2026, 9:50 p.m.
NER Named-entity recognition batch_69abe08fe3248190a6bb7de2a2c317b1 completed March 7, 2026, 8:23 a.m.
NED1 Entity disambiguation (via context triple) batch_69b055fe13448190bf25832219fd5f0c completed March 10, 2026, 5:33 p.m.
Created at: March 6, 2026, 10:10 p.m.